182 related articles for article (PubMed ID: 1377590)
1. [Prospective study on the diagnosis of hepatocellular carcinoma by using alpha-fetoprotein reactive to lentil lectin].
Tu Z
Zhonghua Yi Xue Za Zhi; 1992 Mar; 72(3):138-40, 189. PubMed ID: 1377590
[TBL] [Abstract][Full Text] [Related]
2. Alpha-fetoprotein reaction to Pisum sativum agglutinin in differentiation of benign liver diseases from hepatocellular carcinoma.
Yin ZF; Tu ZX; Cui ZF; Wu MC
Chin Med J (Engl); 1993 Aug; 106(8):615-8. PubMed ID: 7693403
[TBL] [Abstract][Full Text] [Related]
3. A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients.
Shiraki K; Takase K; Tameda Y; Hamada M; Kosaka Y; Nakano T
Hepatology; 1995 Sep; 22(3):802-7. PubMed ID: 7544756
[TBL] [Abstract][Full Text] [Related]
4. [Tumor markers of hepatocellular carcinoma].
Kubo S; Matsukawa M
Gan To Kagaku Ryoho; 2004 Dec; 31(13):2203-6. PubMed ID: 15628773
[TBL] [Abstract][Full Text] [Related]
5. Prospective study on the diagnosis of hepatocellular carcinoma by using alpha-fetoprotein reactive to lentil lectin.
Tu Z; Yin Z; Wu M
Chin Med Sci J; 1992 Dec; 7(4):191-6. PubMed ID: 1339156
[TBL] [Abstract][Full Text] [Related]
6. [Clinical usefulness of lectin-reactive fraction of alpha-fetoprotein in hepatocellular carcinoma].
Tamura A; Oita T; Sakizono K; Nakajima T; Kasakura S
Rinsho Byori; 1998 Feb; 46(2):158-62. PubMed ID: 9528340
[TBL] [Abstract][Full Text] [Related]
7. Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers.
Tateishi R; Shiina S; Yoshida H; Teratani T; Obi S; Yamashiki N; Yoshida H; Akamatsu M; Kawabe T; Omata M
Hepatology; 2006 Dec; 44(6):1518-27. PubMed ID: 17133456
[TBL] [Abstract][Full Text] [Related]
8. Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma.
Tada T; Kumada T; Toyoda H; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kitabatake S; Kuzuya T; Nonogaki K; Shimizu J; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J; Satomura S
Liver Int; 2005 Aug; 25(4):848-53. PubMed ID: 15998436
[TBL] [Abstract][Full Text] [Related]
9. [The studies on early warning of Lens culinaris-reactive alpha-Fetoprotein (AFP-L3) detecting in primary hepatocellular carcinoma].
Li YL; Ma HB; Guo JX; Shi JB; Xu J; Liu AX; Yang LH; Li BA; Mao YL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct; 22(5):336-8. PubMed ID: 19469167
[TBL] [Abstract][Full Text] [Related]
10. [Early detection of hepatocellular carcinoma with lectin reactive alpha-fetoprotein].
Matsuyama H; Morishita Y; Nakane K; Fukatsu T; Nakashima N
Rinsho Byori; 1994 Oct; 42(10):1021-8. PubMed ID: 7527871
[TBL] [Abstract][Full Text] [Related]
11. Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma.
Sterling RK; Jeffers L; Gordon F; Venook AP; Reddy KR; Satomura S; Kanke F; Schwartz ME; Sherman M
Clin Gastroenterol Hepatol; 2009 Jan; 7(1):104-13. PubMed ID: 18849011
[TBL] [Abstract][Full Text] [Related]
12. Lectin-affinity electrophoresis for the detection of AFP microheterogeneities in patients with hepatocellular carcinoma.
Zaninotto M; Ujka F; Lachin M; Bernardi D; Marafi C; Farinati F; Plebani M
Anticancer Res; 1996; 16(1):305-9. PubMed ID: 8615626
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a Thai referral population.
Tanwandee T; Setthasin S; Charatcharoenwitthaya P; Chainuvati S; Leelakusolvong S; Pausawasdi N; Srikureja W; Pongprasobchai S; Manatsathit S; Kachintorn U; Ekpo P; Senawong S
J Med Assoc Thai; 2009 Mar; 92 Suppl 2():S49-56. PubMed ID: 19562986
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of measurement of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and recurrence of small hepatocellular carcinoma.
Hayashi K; Kumada T; Nakano S; Takeda I; Sugiyama K; Kiriyama S; Sone Y; Miyata A; Shimizu H; Satomura S
Am J Gastroenterol; 1999 Oct; 94(10):3028-33. PubMed ID: 10520864
[TBL] [Abstract][Full Text] [Related]
15. A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma.
Taketa K; Endo Y; Sekiya C; Tanikawa K; Koji T; Taga H; Satomura S; Matsuura S; Kawai T; Hirai H
Cancer Res; 1993 Nov; 53(22):5419-23. PubMed ID: 7693340
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
Ishii M; Gama H; Chida N; Ueno Y; Shinzawa H; Takagi T; Toyota T; Takahashi T; Kasukawa R
Am J Gastroenterol; 2000 Apr; 95(4):1036-40. PubMed ID: 10763956
[TBL] [Abstract][Full Text] [Related]
17. [Clinical application studies on AFP-L3 detected by micro-spin column method].
Gao J; Xu AF; Zheng HY; Chen G; Wang MC; Lou GQ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Dec; 24(6):461-3. PubMed ID: 21604577
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
[TBL] [Abstract][Full Text] [Related]
19. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma.
Aoyagi Y; Oguro M; Yanagi M; Mita Y; Suda T; Suzuki Y; Hata K; Ichii K; Asakura H
Cancer; 1996 May; 77(9):1781-6. PubMed ID: 8646674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
